PMVP
PMV Pharmaceuticals, Inc.
$1.41
-0.70%
2026-05-08
About PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Key Fundamentals
Forward P/E
-1.28
EPS (TTM)
$-1.48
ROE
-55.4%
Profit Margin
0.0%
Debt/Equity
0.80
Price/Book
0.72
Beta
1.41
Market Cap
$75.2M
Avg Volume (10D)
261K
Recent Breakout Signals
No recent breakout signals detected for PMVP.
Recent Price Range (60 Days)
60D High
$1.88
60D Low
$1.02
Avg Volume
637K
Latest Close
$1.41
Get breakout alerts for PMVP
Sign up for Breakout Scanner to receive daily notifications when PMVP triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
PMV Pharmaceuticals, Inc. (PMVP) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors PMVP daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. PMVP operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.